Hubei Guangji Pharmaceutical Co., Ltd. operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hubei Guangji Pharmaceutical Co., Ltd. with three other
companies in this sector in China:
Hunan Hansen Pharmaceutical Company Limited
sales of 829.94 million Chinese Renmimbi [US$121.04 million]
of which 100%
was Medical Industry),
Qianjiang Yongan Pharmaceutical Co Ltd
(932.77 million Chinese Renmimbi [US$136.04 million]
of which 78%
was Medical Manufacturing), and
Jilin Jian Yisheng Pharmaceutical Company Limited
(1.03 billion Chinese Renmimbi [US$150.86 million]
of which 68%
Hubei Guangji Pharmaceutical Co., Ltd. reported sales of 801.56 million Chinese Renmimbi (US$116.90 million)
December of 2017.
increase of 12.9%
versus 2016, when the company's sales were 709.98 million Chinese Renmimbi.
This was the third consecutive year of growth at Hubei Guangji Pharmaceutical Co., Ltd..